SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001493152-18-004829
Filing Date
2018-04-05
Accepted
2018-04-05 15:35:00
Documents
5
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 form10-ka.htm 10-K/A 1778377
2 ex23-1.htm EX-23.1 3253
3 ex23-2.htm EX-23.2 3502
4 ex31-2.htm EX-31.2 21955
5 ex32-1.htm EX-32.1 11572
  Complete submission text file 0001493152-18-004829.txt   1819962
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

IRS No.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-51353 | Film No.: 18740408
SIC: 7389 Services-Business Services, NEC